Murray Alzheimer Research and Education Program (MAREP)
Alzheimer's disease and related dementias are a world-wide phenomenon that ignores social class and national boundaries. As age is the greatest risk factor for the development of Alzheimer's disease, more and more individuals will be diagnosed with Alzheimer's disease and related dementias as the population ages.
At the present time there is no known cause or cure for Alzheimer's disease. As the search for an effective treatment continues, it is important that people who have Alzheimer's disease or a related dementia receive the best care possible and are provided with support and opportunities to live meaningful lives.
To implement effective approaches for care of people living with Alzheimer's disease and related dementias, contemporary research findings need to be brought to the attention of all partners in care including people with dementia, family members and friends, health care professionals, and so forth. The converse is true as well in that effective approaches to care need to be brought to the attention of researchers.
The Murray Alzheimer Research and Education Program (MAREP) is an innovative program that adopts a partnership approach and integrates research and educational activities in an effort to improve dementia care practices in Canada and around the world. Although MAREP's research projects are funded by research grants, all of its knowledge translation activities are funded through donations and charitable gifts from individuals and groups: find out how you can support our programs.
More information is available for people living with dementia, care partners, and anyone else affected by dementia in our Innovations Newsletter, published three times per year, the Dementia Weekly News Service, our blog, and the educational tools and training and workshops we offer.
- Nov. 20, 2017
According to a new study, there was a 29 percent lower chance of developing dementia in older adults who participated in specific computer training. This training was done to check response times to visual stimuli to test plasticity of the brain, decision-making, perception skills, thinking and memory. More than 2,800 people were included in the randomized clinical trials of this brain training that was funded by the US National Institutes of Health. The brain-training program, created by Posit Science, is called “Double Decision” and is available at BrainHQ.com.
- Nov. 20, 2017
A recent paper, from researchers at Brigham and Women's Hospital, investigated why some brain regions degenerate with the development of Alzheimer’s disease, while other regions seem to be protected from the condition’s effects. The paper that will be published in Stem Cell Reports, has discovered that certain patterns of degeneration, and the areas that are vulnerable to it, can be linked to specific encoding factors found in the DNA of the different brain regions.
- Nov. 20, 2017
On Sunday it was announced that Bill Gates, billionaire and Microsoft co-founder, was going to be investing $100 million dollars into researching dementia and Alzheimer’s disease. Gates is hoping that his contribution will aide in finding a significant medical treatment for Alzheimer’s disease because, out of the top ten causes of death, it is the only one that currently does not have one.
- July 25, 2017
Last month, Bill C-233, an Act respecting a national strategy for Alzheimer’s disease and other dementias, sponsored by the Honourable Rob Nicholson and Rob Oliphant, was passed. Canada will be the 30th country out of 194 members of the World Health Organization to implement a national dementia plan.
- June 6, 2017
Hi I am your assignment for today.
I know I am just one of many but I ask you to please take the time to know me. You see I once was also a nurse. That really doesn't matter as I am a human being. I come with an education and feeling. I am also a wife a mother, a grandmother and more. Please take the time to read my chart as you can gain much knowledge about me before you ever meet me. In it you will find my medical history, this may give you a glimpse of what to expect from me. It will tell you what is being treated now. Know full well that, that may not be my only problem.
- May 2, 2017
A Letter from the Chair
Hello, ODAG Members, Friends, and Supporters.
The last two months have been very interesting for people living with dementia. It is a time of policy changes, budget allocations and the broadening of the Council of Canadians with Disabilities to formally include people living with dementia.